{
  "industry": "chemistry",
  "stage": "series-a",
  "pageType": "diligence-checklist",
  "slug": "/investor-questions/chemistry/series-a/diligence-checklist/",
  "ctaText": "Create your PitchChat room",
  "dataOrigin": "editorial",
  "sourceId": "editorial-chemistry-series-a",
  "sourceNotes": "Editorial guidance prepared by Pitchchat; not sourced from user submissions.",
  "sourceTags": [
    "editorial",
    "pitchchat-guidance"
  ],
  "title": "Chemistry Series A diligence checklist",
  "summary": "Series A biotech diligence is comprehensive, covering clinical data depth, regulatory documentation, manufacturing readiness, and team capability. Expect expert scientific review and significant documentation requirements. Quality and transparency reflect operational maturity. Pitchchat keeps diligence docs organized and easy to review.",
  "items": [
    {
      "item": "Complete clinical data package with statistical analysis",
      "rationale": "All clinical trial data with full statistical analysis. Study reports, CRFs, and raw data access. Safety database if Phase 1 complete. Biomarker and translational data. Independent statistical review may be conducted."
    },
    {
      "item": "IND documentation or regulatory meeting minutes",
      "rationale": "Complete IND package if filed. All FDA meeting minutes and correspondence. Type A/B/C meeting outcomes. Special designation applications and feedback. Regulatory counsel communications."
    },
    {
      "item": "CMC and manufacturing documentation",
      "rationale": "Chemistry, manufacturing, and controls package. Process development reports. Analytical methods and validation. Stability data. CMO contracts and capacity commitments. Scale-up assessment and timeline."
    },
    {
      "item": "Patent prosecution files and FTO opinions",
      "rationale": "Complete patent prosecution history. Freedom-to-operate opinions from qualified counsel. Patent term analysis and extension strategy. Competitive IP landscape analysis. License agreements if applicable."
    },
    {
      "item": "Clinical operations capability assessment",
      "rationale": "Clinical trial plans with site identification. CRO relationships and contracts. Patient recruitment strategy validation. Clinical operations team capability. Trial budget and timeline with assumptions."
    },
    {
      "item": "Competitive intelligence documentation",
      "rationale": "Detailed competitive landscape with clinical-stage programs. Head-to-head positioning analysis. Competitive program failures and implications. Market research and physician feedback. Competitive monitoring process."
    },
    {
      "item": "Financial model with milestone scenarios",
      "rationale": "Detailed financial projections through key milestones. Scenario analysis: base, upside, downside. Cash burn and runway analysis. Partnership scenario economics. Capital requirements through approval."
    },
    {
      "item": "Partnership documentation and pharma interest",
      "rationale": "CDA log with pharma companies. Diligence request and response documentation. Any term sheets or indications of interest. Partnership strategy and timing analysis. Comparable transaction analysis."
    },
    {
      "item": "Team backgrounds with drug development track record",
      "rationale": "Detailed CVs for all key personnel. Drug development contributions verified. Reference checks on key team members. Organizational structure and capability gaps. Hiring plan with budget."
    },
    {
      "item": "Scientific advisory board documentation",
      "rationale": "SAB member agreements and engagement evidence. KOL relationships for clinical trials. Scientific advisory meeting minutes. Publication strategy. Expert network access."
    },
    {
      "item": "Risk register and mitigation plans",
      "rationale": "Comprehensive risk assessment: clinical, regulatory, competitive, commercial. Risk mitigation strategies with owners. Pivot options if primary approach fails. Board risk discussions documented."
    },
    {
      "item": "Legal and corporate documentation",
      "rationale": "Cap table with all instruments. Material contracts: licenses, collaborations, CMOs. Corporate governance documentation. Employee agreements and IP assignment. Litigation or threatened claims."
    }
  ]
}